Undifferentiated high-grade pleomorphic sarcoma (UHPS): Diagnostic criteria, differential diagnosis, and treatment. An attempt to erasure the misnomer "MFH"

European Surgery - Acta Chirurgica Austriaca

Volumn 41, Issue 4, 2009, Pages 143-149

  Liegl Atzwanger, Bernadette ^a   Hofmann, G ^a   Leithner, A ^a   Beham, A ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

High grade pleomorphic sarcoma; MFH; Sarcoma; Undifferentiated sarcoma

Indexed keywords

ARTICLE; CANCER CENTER; CANCER CLASSIFICATION; CANCER GRADING; CANCER LOCALIZATION; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CYTOGENETICS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; ELECTRON MICROSCOPY; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT FIBROUS HISTIOCYTOMA; MEDICAL SPECIALIST; NOMOGRAM; PROGNOSIS; SOFT TISSUE SARCOMA; TREATMENT PLANNING; TUMOR RECURRENCE; TUMOR VOLUME; UNDIFFERENTIATED CARCINOMA;

EID: 70349311691     PISSN: 16828631     EISSN: 16824016     Source Type: Journal    
DOI: 10.1007/s10353-009-0474-9     Document Type: Article

References (36)

1. O'Brien JE, Stout AP. Malignant Fibrous Xanthomas. Cancer 1964;17:1445-55
2. Ozzello L, Stout AP, Murray MR. Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer 1963;16:331-44
3. Kempson RL, Kyriakos M. Fibroxanthosarcoma of the soft tissues. A type of malignant fibrous histiocytoma. Cancer 1972;29:961-76
4. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: An analysis of 200 cases. Cancer 1978;41:2250-66
5. Enzinger FM. Angiomatoid malignant fibrous histiocytoma: A distinct fibrohistiocytic tumor of children and young adults simulating a vascular neoplasm. Cancer 1979;44:2147-57
6. Guccion JG, Enzinger FM. Malignant giant cell tumor of soft parts. An analysis of 32 cases. Cancer 1972;29:1518-29
7. Kyriakos M, Kempson RL. Inflammatory fibrous histiocytoma. An aggressive and lethal lesion. Cancer 1976;37:1584-606
8. Weiss SW, Enzinger FM. Myxoid variant of malignant fibrous histiocytoma. Cancer 1977;39:1672-85
9. Bertoni F, Capanna R, Biagini R, Bacchini P, Guerra A, Ruggieri P, et al. Malignant fibrous histiocytoma of soft tissue. An analysis of 78 cases located and deeply seated in the extremities. Cancer 1985;56:356-67
10. Enjoji M, Hashimoto H, Tsuneyoshi M, Iwasaki H. Malignant fibrous histiocytoma. A clinicopathologic study of 130 cases. Acta Pathol Jpn 1980;30:727-41
11. Fletcher CD, Unni KK, Mertens F. WHO Classification of tumors. Pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press; 2002
12. Brooks JJ. The significance of double phenotypic patterns and markers in human sarcomas. A new model of mesenchymal differentiation. Am J Pathol 1986;125:113-23
13. Dehner LP. Malignant fibrous histiocytoma. Nonspecific morphologic pattern, specific pathologic entity, or both? Arch Pathol Lab Med 1988;112:236-7
14. Coindre JM, Mariani O, Chibon F, Mairal A, De Saint Aubain Somerhausen N, Favre-Guillevin E, et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: A review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol 2003;16:256-62
15. Fletcher CD. Pleomorphic malignant fibrous histiocytoma: Fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 1992;16:213-28
16. Fletcher CD, Gustafson P, Rydholm A, Willen H, Akerman M. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 2001;19:3045-50
17. Oda Y, Tamiya S, Oshiro Y, Hachitanda Y, Kinukawa N, Iwamoto Y, et al. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts. Pathol Int 2002;52:595-606
18. Angervall L, Kindblom LG, Merck C. Myxofibrosarcoma. A study of 30 cases. Acta Pathol Microbiol Scand [A] 1977;85A:127-40
19. Hollowood K, Fletcher CD. Malignant fibrous histiocytoma: Morphologic pattern or pathologic entity? Semin Diagn Pathol 1995;12:210-20
20. Antonescu CR, Dal Cin P, Nafa K, Teot LA, Surti U, Fletcher CD, et al. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer 2007;46:1051-60
21. Rossi S, Szuhai K, Ijszenga M, Tanke HJ, Zanatta L, Sciot R, et al. EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma. Clin Cancer Res 2007;13:7322-8
22. Deyrup AT, Haydon RC, Huo D, Ishikawa A, Peabody TD, He TC, et al. Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity: An analysis of 92 cases. Cancer 2003;98:805-13
23. Massi D, Beltrami G, Capanna R, Franchi A. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance. Eur J Surg Oncol 2004;30:1131-6
24. Binh MB, Sastre-Garau X, Guillou L, de Pinieux G, Terrier P, Lagace R, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: A comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 2005;29:1340-7
25. Pilotti S, Della Torre G, Mezzelani A, Tamborini E, Azzarelli A, Sozzi G, et al. The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma. Br J Cancer 2000;82:1271-5
26. Pilotti S, Della Torre G, Lavarino C, Sozzi G, Minoletti F, Vergani B, et al. Molecular abnormalities in liposarcoma: Role of MDM2 and CDK4-containing amplicons at 12q13-22. J Pathol 1998;185:188-90
27. Hornick JL, Bosenberg MW, Mentzel T, McMenamin ME, Oliveira AM, Fletcher CD. Pleomorphic liposarcoma: Clinicopathologic analysis of 57 cases. Am J Surg Pathol 2004;28:1257-67
28. Nascimento AF, Bertoni F, Fletcher CD. Epithelioid variant of myxofibrosarcoma: Expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases. Am J Surg Pathol 2007;31:99-105
29. Mentzel T, Calonje E, Wadden C, Camplejohn RS, Beham A, Smith MA, et al. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 1996;20:391-405
30. O'Connell JX, Wehrli BM, Nielsen GP, Rosenberg AE. Giant cell tumors of soft tissue: A clinicopathologic study of 18 benign and malignant tumors. Am J Surg Pathol 2000;24:386-95
31. Oliveira AM, Dei Tos AP, Fletcher CD, Nascimento AG. Primary giant cell tumor of soft tissues: A study of 22 cases. Am J Surg Pathol 2000;24:248-56
32. Mertens F, Fletcher CD, Dal Cin P, De Wever I, Mandahl N, Mitelman F, et al. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: A report of the CHAMP Study Group. Chromosomes and MorPhology. Genes Chromosomes Cancer 1998;22:16-25
33. Forus A, Weghuis DO, Smeets D, Fodstad O, Myklebost O, van Kessel AG. Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer 1995;14:8-14
34. Larramendy ML, Tarkkanen M, Blomqvist C, Virolainen M, Wiklund T, Asko-Seljavaara S, et al. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol 1997;151:1153-61
35. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002;20(1):791-6
36. Tunn PU, Kettelhack C, Durr HR. Standardized approach to the treatment of adult soft tissue sarcoma of the extremities. Recent Results Cancer Res 2009;179:211-28